Zavoico, senior life sciences analyst at investment research firm MLV, forecasts that the bioscan removal will enable Spectrum to post record earnings in the fiscal third quarter of 2012.
The election of Nematandani last year was seen as a major triumph for Jordaan and his associates, while the removal of Hack from his post this week has also been seen as a move that has further strengthened their position.